• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肾透明细胞癌关键基因和通路的生物信息学与功能分析

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.

作者信息

Wang Jinxing, Yuan Lushun, Liu Xingnian, Wang Gang, Zhu Yuan, Qian Kaiyu, Xiao Yu, Wang Xinghuan

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

出版信息

Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473. Epub 2018 Apr 12.

DOI:10.3892/ol.2018.8473
PMID:29805645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5958663/
Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. The present study was conducted to explore the mechanisms and identify the potential target genes for ccRCC using bioinformatics analysis. The microarray data of GSE15641 were screened on Gene-Cloud of Biotechnology Information (GCBI). A total of 32 ccRCC samples and 23 normal kidney samples were used to identify differentially expressed genes (DEGs) between them. Subsequently, the clustering analysis and functional enrichment analysis of these DEGs were performed, followed by protein-protein interaction (PPI) network, and pathway relation network. Additionally, the most significant module based on PPI network was selected, and the genes in the module were identified as hub genes. Furthermore, transcriptional level, translational level and survival analyses of hub genes were performed to verify the results. A total of 805 genes, 403 upregulated and 402 downregulated, were differentially expressed in ccRCC samples compared with normal controls. The subsequent bioinformatics analysis indicated that the small molecule metabolic process and the metabolic pathway were significantly enriched. A total of 7 genes, including membrane metallo-endopeptidase (), albumin (), cadherin 1 (), prominin 1 (), chemokine () ligand 12 (), protein tyrosine phosphatase receptor type C () and intercellular adhesion molecule 1 () were identified as hub genes. In brief, the present study indicated that these candidate genes and pathways may aid in deciphering the molecular mechanisms underlying the development of ccRCC, and may be used as therapeutic targets and diagnostic biomarkers of ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是最常见的肾癌类型。本研究旨在通过生物信息学分析探索ccRCC的发病机制并确定潜在的靶基因。在生物技术信息基因云(GCBI)上筛选了GSE15641的微阵列数据。共使用32例ccRCC样本和23例正常肾样本确定它们之间的差异表达基因(DEG)。随后,对这些DEG进行聚类分析和功能富集分析,接着构建蛋白质-蛋白质相互作用(PPI)网络和通路关系网络。此外,基于PPI网络选择最显著的模块,并将该模块中的基因确定为枢纽基因。进一步对枢纽基因进行转录水平、翻译水平和生存分析以验证结果。与正常对照相比,ccRCC样本中共有805个基因差异表达,其中403个上调,402个下调。随后的生物信息学分析表明小分子代谢过程和代谢途径显著富集。共有7个基因被确定为枢纽基因,包括膜金属内肽酶()、白蛋白()、钙黏蛋白1()、多配体蛋白聚糖1()、趋化因子()配体12()、蛋白酪氨酸磷酸酶受体C型()和细胞间黏附分子1()。简而言之,本研究表明这些候选基因和途径可能有助于阐明ccRCC发生发展的分子机制,并可作为ccRCC的治疗靶点和诊断生物标志物。

相似文献

1
Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.人肾透明细胞癌关键基因和通路的生物信息学与功能分析
Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473. Epub 2018 Apr 12.
2
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.通过综合生物信息学分析鉴定 CXCL13 作为透明细胞肾细胞癌的潜在生物标志物。
Biomed Pharmacother. 2019 Oct;118:109264. doi: 10.1016/j.biopha.2019.109264. Epub 2019 Aug 4.
3
Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.生物信息学分析和验证肾透明细胞癌的基因靶点。
Comput Biol Chem. 2021 Jun;92:107453. doi: 10.1016/j.compbiolchem.2021.107453. Epub 2021 Feb 9.
4
Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.通过共表达分析鉴定人透明细胞肾细胞癌(ccRCC)中的关键基因和通路。
Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018.
5
The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.转移性肾细胞癌关键基因表达特征及生物学通路的鉴定
J Cancer. 2020 Jan 16;11(7):1712-1726. doi: 10.7150/jca.38379. eCollection 2020.
6
The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.肾癌中关键基因表达特征和生物标志物的筛选
J Cancer. 2019 Oct 19;10(25):6384-6394. doi: 10.7150/jca.30656. eCollection 2019.
7
Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.CCND1和PECAM1/CD31用于预测肾细胞癌患者预后的筛选、鉴定及验证
Aging (Albany NY). 2019 Dec 18;11(24):12057-12079. doi: 10.18632/aging.102540.
8
Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma.透明细胞肾细胞癌关键基因的生物信息学鉴定及预后价值分析
Oncol Lett. 2018 Aug;16(2):1747-1757. doi: 10.3892/ol.2018.8842. Epub 2018 May 30.
9
Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.通过共表达分析鉴定出与透明细胞肾细胞癌进展和预后相关的 15 个枢纽基因。
J Cell Physiol. 2019 Jul;234(7):10225-10237. doi: 10.1002/jcp.27692. Epub 2018 Nov 11.
10
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.用于鉴定影响透明细胞肾细胞癌发病机制的潜在关键基因的综合生物信息学分析
Oncol Lett. 2020 Aug;20(2):1573-1584. doi: 10.3892/ol.2020.11703. Epub 2020 Jun 5.

引用本文的文献

1
PROM1 and EFTUD2 Expression in High-Grade Clear Cell Renal Cell Carcinoma as a Molecular Marker for Survival Rate.PROM1和EFTUD2在高级别透明细胞肾细胞癌中的表达作为生存率的分子标志物
Int J Mol Sci. 2025 Jun 30;26(13):6296. doi: 10.3390/ijms26136296.
2
Screening of common genomic biomarkers to explore common drugs for the treatment of pancreatic and kidney cancers with type-2 diabetes through bioinformatics analysis.通过生物信息学分析筛选常见基因组生物标志物,以探索用于治疗2型糖尿病合并胰腺癌和肾癌的常用药物。
Sci Rep. 2025 Mar 2;15(1):7363. doi: 10.1038/s41598-025-91875-3.
3
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.

本文引用的文献

1
Systematic analyses of glutamine and glutamate metabolisms across different cancer types.对不同癌症类型中谷氨酰胺和谷氨酸代谢的系统分析。
Chin J Cancer. 2017 Nov 7;36(1):88. doi: 10.1186/s40880-017-0255-y.
2
Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.TCF21 mRNA 表达对肺腺癌患者的预后意义。
Sci Rep. 2017 May 17;7(1):2027. doi: 10.1038/s41598-017-02290-2.
3
Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
通过生存分析筛选差异基因表达模式,用于透明细胞肾细胞癌的诊断、预后和治疗。
PLoS One. 2024 Sep 30;19(9):e0310843. doi: 10.1371/journal.pone.0310843. eCollection 2024.
4
A systematic investigation of clear cell renal cell carcinoma using meta-analysis and systems biology approaches.采用荟萃分析和系统生物学方法对透明细胞肾细胞癌进行系统研究。
Mol Genet Genomics. 2024 Sep 16;299(1):87. doi: 10.1007/s00438-024-02180-z.
5
Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications.生物信息学分析揭示 2 型糖尿病与透明细胞肾细胞癌之间的共享分子机制及治疗指征。
Sci Rep. 2024 Aug 19;14(1):19133. doi: 10.1038/s41598-024-69302-w.
6
Comprehensive analysis of gene expression profiles of annulus fibrosus subtypes and hub genes in intervertebral disc degeneration.全面分析纤维环亚型和椎间盘退变中枢纽基因的基因表达谱。
Aging (Albany NY). 2024 Mar 13;16(6):5370-5386. doi: 10.18632/aging.205653.
7
DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis.DLK2 通过生物信息学分析作为透明细胞肾细胞癌的潜在预后生物标志物。
Genes (Basel). 2022 Apr 1;13(4):629. doi: 10.3390/genes13040629.
8
Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.鉴定CXCL10作为透明细胞肾细胞癌的预后生物标志物
Front Oncol. 2022 Feb 28;12:857619. doi: 10.3389/fonc.2022.857619. eCollection 2022.
9
The Role of CXCL12 in Kidney Diseases: A Friend or Foe?CXCL12在肾脏疾病中的作用:是友还是敌?
Kidney Dis (Basel). 2021 May;7(3):176-185. doi: 10.1159/000514913. Epub 2021 Apr 6.
10
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.外视网膜膜蛋白 1 可作为肿瘤抑制因子抑制肺癌进展。
Comput Math Methods Med. 2021 Feb 17;2021:6651764. doi: 10.1155/2021/6651764. eCollection 2021.
对E-钙黏蛋白(CDH1)缺陷型遗传性弥漫性胃癌(HDGC)细胞进行转录组分析和定量高通量(qHTS)药物筛选,确定了家族性胃癌的治疗线索。
J Transl Med. 2017 May 1;15(1):92. doi: 10.1186/s12967-017-1197-5.
4
Fire and water: Tumor cell adaptation to metabolic conditions.火与水:肿瘤细胞对代谢条件的适应
Exp Cell Res. 2017 Jul 15;356(2):204-208. doi: 10.1016/j.yexcr.2017.04.029. Epub 2017 Apr 27.
5
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.布鲁顿酪氨酸激酶抑制剂依鲁替尼通过调节肿瘤浸润巨噬细胞发挥免疫调节作用。
Oncotarget. 2017 Jun 13;8(24):39218-39229. doi: 10.18632/oncotarget.16836.
6
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.尿液中的RKIP/磷酸化RKIP是透明细胞肾细胞癌潜在的诊断和预后标志物。
Oncotarget. 2017 Jun 20;8(25):40412-40424. doi: 10.18632/oncotarget.16341.
7
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
8
Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development.在支气管肺发育不良的发展过程中,血管生成相关基因可能是比基质金属蛋白酶更重要的因素。
Oncotarget. 2017 Mar 21;8(12):18670-18679. doi: 10.18632/oncotarget.14722.
9
Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.数字PCR鉴定肠型胃癌中CDH1(E-钙黏蛋白)转录模式的变化。
Oncotarget. 2017 Mar 21;8(12):18811-18820. doi: 10.18632/oncotarget.13401.
10
Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.蛋白质转录组学分析揭示了透明细胞肾细胞癌分子格局的阶段特异性变化。
PLoS One. 2016 Apr 29;11(4):e0154074. doi: 10.1371/journal.pone.0154074. eCollection 2016.